SPRY vs. PG
SPRY (Silverback Therapeutics Inc) and PG (The Procter & Gamble Company) are both stocks. SPRY operates in Biotechnology (Healthcare), while PG operates in Household & Personal Products (Consumer Defensive). Over the past 5 years, SPRY returned -20.88%/yr vs 5.19%/yr for PG. At a 0.02 correlation, their price movements are largely independent.
Performance
SPRY vs. PG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPRY achieves a -11.76% return, which is significantly lower than PG's 6.81% return.
SPRY
- 1D
- 3.01%
- 1M
- 29.47%
- YTD
- -11.76%
- 6M
- -6.80%
- 1Y
- -37.96%
- 3Y*
- 17.85%
- 5Y*
- -20.88%
- 10Y*
- —
PG
- 1D
- 2.15%
- 1M
- 4.44%
- YTD
- 6.81%
- 6M
- 6.91%
- 1Y
- -3.62%
- 3Y*
- 3.18%
- 5Y*
- 5.19%
- 10Y*
- 9.19%
SPRY vs. PG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SPRY Silverback Therapeutics Inc | -11.76% | 10.43% | 92.52% | -35.76% | 28.08% | -85.63% | 59.79% |
PG The Procter & Gamble Company | 6.81% | -12.26% | 17.25% | -0.86% | -5.05% | 20.52% | 1.31% |
Correlation
The correlation between SPRY and PG is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Dec 4, 2020 | 0.02 |
Fundamentals
SPRY:
$1.02B
PG:
$364.55B
SPRY:
-$2.00
PG:
$5.23
SPRY:
10.26
PG:
4.23
SPRY:
16.65
PG:
6.75
SPRY:
$98.99M
PG:
$86.72B
SPRY:
$59.93M
PG:
$43.64B
SPRY:
-$194.60M
PG:
$22.63B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPRY vs. PG — Risk / Return Rank
SPRY
PG
SPRY vs. PG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPRY | PG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.38 | ||
| Sortino ratioReturn per unit of downside risk | -0.43 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.98 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.60 | -0.23 | -0.37 |
| Martin ratioReturn relative to average drawdown | -0.85 | -0.43 | -0.43 |
Loading charts...
Drawdowns
SPRY vs. PG - Drawdown Comparison
The maximum SPRY drawdown since its inception was -95.20%, which is greater than PG's maximum drawdown of -54.25%. Use the drawdown chart below to compare losses from any high point for SPRY and PG.
Loading charts...
Drawdown Indicators
| SPRY | PG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.20% | -54.25% | -40.95% |
Max Drawdown (1Y)Largest decline over 1 year | -63.32% | -15.52% | -47.80% |
Max Drawdown (3Y)Largest decline over 3 years | -63.32% | -21.15% | -42.17% |
Max Drawdown (5Y)Largest decline over 5 years | -91.77% | -23.77% | -68.00% |
Max Drawdown (10Y)Largest decline over 10 years | — | -23.77% | — |
Current DrawdownCurrent decline from peak | -82.98% | -12.57% | -70.41% |
Average DrawdownAverage peak-to-trough decline | -78.26% | -12.16% | -66.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.52% | 8.48% | +36.04% |
Volatility
SPRY vs. PG - Volatility Comparison
Silverback Therapeutics Inc (SPRY) has a higher volatility of 18.34% compared to The Procter & Gamble Company (PG) at 7.62%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPRY | PG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.34% | 7.62% | +10.72% |
Volatility (6M)Calculated over the trailing 6-month period | 45.49% | 15.05% | +30.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.37% | 18.92% | +47.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.08% | 17.86% | +62.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.79% | 19.08% | +61.71% |
Dividends
SPRY vs. PG - Dividend Comparison
SPRY has not paid dividends to shareholders, while PG's dividend yield for the trailing twelve months is around 2.82%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PG The Procter & Gamble Company | 2.82% | 2.91% | 2.36% | 2.55% | 2.38% | 2.08% | 2.24% | 2.37% | 3.09% | 2.98% | 3.18% | 3.31% |
SPRY Silverback Therapeutics Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SPRY vs. PG - Financials Comparison
This section allows you to compare key financial metrics between Silverback Therapeutics Inc and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SPRY and PG have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPRY has higher volatility (18.34%) compared to PG (7.62%). In terms of maximum drawdown, SPRY dropped -95.20% vs PG's -54.25%.
PG currently has the higher Sharpe Ratio (-0.19 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPRY and PG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer